adplus-dvertising
Connect with us

Business

The hunt for a vaccine: Canadian company begins human testing of COVID-19 candidate – CTV News

Published

 on


TORONTO —
A Quebec City biopharmaceutical company began clinical trials on humans on Monday for a plant-derived COVID-19 vaccine.

Medicago is the first Canadian company to administer doses of a potential vaccine to volunteers, 180 men and women aged 18 to 55 who will receive two doses 21 days apart. The company expects to have safety and efficacy results for the two doses in October.

“(The) timeline is very aggressive and in fact we’re trying to do in 18 months what normally requires five to six years,” Nathalie Landry, executive vice-president of scientific and medical affairs at Medicago, told CTV News medical correspondent Avis Favaro.

“It’s a race. It is a race to find treatments to be able to vaccinate the population so we can get this COVID-19 under control.”

Unlike traditional vaccine development, Medicago does not use animal products or live viruses to create its products. The company says it uses “virus-like particles (VLPs) that mimic the shape and dimensions of a virus, which allows the body to recognize them and create an immune response in a non-infectious way.”

The company announced on March 12 that it had produced a VLP vaccine, 20 days after obtaining the SARS-CoV-2 gene that is responsible for COVID-19. It said in a news release at the time that it was collaborating with Laval University’s Infectious Disease Research Centre headed by Dr. Gary Kobinger, who helped develop a vaccine and treatment for Ebola.

Medicago says its clinical trial data in developing an influenza vaccine, which is now being reviewed for approval by Health Canada, along with its research into an H1N1 vaccine, shows that “VLPs have a multi-modal mechanism of action that is different from that of inactivated vaccines, activating both arms of the immune system – antibody and cell-mediated responses.”

Landry says its COVID-19 vaccine candidate stimulated a “very high neutralizing antibody response” in mice, along with activating the body’s T-cells, a major component of the immune system.

At least two other vaccine developers are expected to enter candidates into clinical trials in Canada soon.

According to Health Canada’s list of authorized clinical trials to investigate drug treatments and vaccines for the novel coronavirus, Medicago got approval to move forward with Phase 1 clinical trials July 9. 

Health Canada has authorized only two potential vaccines to go to clinical trials in this country so far. The other and the first, Ad5-nCoV that was developed by CanSino Biologics and Chinese government scientists, was to be tested in clinical trials conducted by the Canadian Center for Vaccinology (CCV) at Dalhousie University in Halifax.

Health Canada approval came through May 15 and clinical trials were to begin within weeks, but the CCV is now indicating they have been held up because the Chinese government has not approved sending the vaccine candidate to Canada. 

Edmonton-based biotechnology firm Entos Pharmaceuticals is working on a relatively new kind of treatment known as a DNA vaccine. Unlike other vaccines, which prompt a body to develop an immunity to a disease, DNA vaccines inject pieces of DNA code into cells, directly instructing them to produce an antibody that stops the virus.

Entos says it has developed two potential “pan-coronavirus” vaccines.

In a June 25 press release, company CEO John Lewis said preclinical results showed the company’s candidates “have the potential to be safe and highly potent vaccines that will provide protection against COVID-19 as well as future coronavirus threats.”

Lewis, a cancer researcher at the University of Alberta, confirmed to CTV News that Entos is on track to begin its clinical trials beginning with 70 to 75 volunteers in August. Entos has partnered with the CCV to carry out the human clinical trials and says it aims to develop a safe and effective vaccine for COVID-19 in one year.

Medicago is evaluating three dosage levels of the vaccine, both alone and in conjunction with two already-approved adjuvants.

“An adjuvant can be of particular importance in a pandemic situation as it may boost the immune response and reduce the amount of antigen required per dose, allowing more vaccine doses to be produced and therefore contributing to protect the greatest number of people,” the company said in a news release.

Medicago, named after the Latin word for alfalfa, has its origins in a partnership between Agriculture Canada and Laval University. It was incorporated in 1999, went public in 2006, and was acquired by majority shareholder Mitsubishi Tanabe Pharmaceutical Corp. in 2013. It employs 450 people in Canada and the United States.

The Quebec government has invested $7 million in Medicago’s COVID-19 vaccine development and the company is also the recipient of funding through the Government of Canada’s $192-million COVID-19 research fund.

Landry says Medicago believes it is among the first 20 vaccines to move into clinical trial in the world, among an estimated 150 that are under development.

No one vaccine will provide a global solution to the pandemic, she says, because no manufacturer can produce enough to vaccinate the world’s population and no one formulation will protect everyone from infants to the elderly.

“We need multiple solutions to make sure that we can protect the population in general, with the most effective vaccine,” she said.

Another Canadian company, IMV, tells CTVNews that it plans to begin human tests later this month of a vaccine, called DPX-COVID-19, that officials say may work well in the elderly and those with immune disorders, two high-risk groups.

The tests will be conducted in healthy adults aged 18 to 84. Two dose levels of DPX-COVID-19 will be tested.

Andrew McArthur, an associate professor in biochemistry and biomedical sciences at McMaster University in Hamilton, Ont., says the Canadian pharmaceutical industry is contributing to “a shotgun approach” to finding answers to the pandemic.

He says the key is many different researchers trying many different solutions with the hope “a handful of them will light and do the job.”

“The more the merrier because it just increases our odds that we’ll get a viable vaccine.”

McArthur, who is lead on a lab that develops biological databases and undertakes genomic sequencing, says constant sequencing of the novel coronavirus shows it isn’t changing, meaning what researchers are working on for a vaccine is a “viable target” and improves the odds that it could work long term.

That makes it different from the influenza virus, which mutates rapidly, requiring a new vaccine each year.

Medicago says it expects to be able to manufacture 100 million doses of a COVID-19 vaccine by the end of 2021 in its facility in North Carolina, and another 10 million in a pilot facility in Quebec City. But when the company completes a new manufacturing centre in Quebec City in 2023, it anticipates annual manufacturing capacity of up to 1 billion doses.

Landry says the company is in discussions about distribution with several governments but nothing is official. She said the “expectation” is that if a deal is reached with the Canadian government that it would reserve doses for the Canadian population.

McArthur cautions there is a range of possible outcomes in the hunt for a vaccine. Scientists might be unsuccessful in developing one that effectively wards off COVID-19, but they might also zero in on one that is so effective it provides life-time immunity.

Or the reality could land somewhere in the middle: with a vaccine formulation that requires a booster every six months.

McArthur says all the global capacity in vaccine development that’s being built now is aimed at this pandemic, but will certainly help in the fight in the next one to come.

Canadian researchers are now “starting a massive national sequencing effort” to track every COVID-19 case, to figure out each genome and understand how it moved around, says McArthur. That is going to help prepare for and control future outbreaks of this virus and viruses yet to emerge. 

Let’s block ads! (Why?)

728x90x4

Source link

Business

Dollarama keeping an eye on competitors as Loblaw launches new ultra-discount chain

Published

 on

 

Dollarama Inc.’s food aisles may have expanded far beyond sweet treats or piles of gum by the checkout counter in recent years, but its chief executive maintains his company is “not in the grocery business,” even if it’s keeping an eye on the sector.

“It’s just one small part of our store,” Neil Rossy told analysts on a Wednesday call, where he was questioned about the company’s food merchandise and rivals playing in the same space.

“We will keep an eye on all retailers — like all retailers keep an eye on us — to make sure that we’re competitive and we understand what’s out there.”

Over the last decade and as consumers have more recently sought deals, Dollarama’s food merchandise has expanded to include bread and pantry staples like cereal, rice and pasta sold at prices on par or below supermarkets.

However, the competition in the discount segment of the market Dollarama operates in intensified recently when the country’s biggest grocery chain began piloting a new ultra-discount store.

The No Name stores being tested by Loblaw Cos. Ltd. in Windsor, St. Catharines and Brockville, Ont., are billed as 20 per cent cheaper than discount retail competitors including No Frills. The grocery giant is able to offer such cost savings by relying on a smaller store footprint, fewer chilled products and a hearty range of No Name merchandise.

Though Rossy brushed off notions that his company is a supermarket challenger, grocers aren’t off his radar.

“All retailers in Canada are realistic about the fact that everyone is everyone’s competition on any given item or category,” he said.

Rossy declined to reveal how much of the chain’s sales would overlap with Loblaw or the food category, arguing the vast variety of items Dollarama sells is its strength rather than its grocery products alone.

“What makes Dollarama Dollarama is a very wide assortment of different departments that somewhat represent the old five-and-dime local convenience store,” he said.

The breadth of Dollarama’s offerings helped carry the company to a second-quarter profit of $285.9 million, up from $245.8 million in the same quarter last year as its sales rose 7.4 per cent.

The retailer said Wednesday the profit amounted to $1.02 per diluted share for the 13-week period ended July 28, up from 86 cents per diluted share a year earlier.

The period the quarter covers includes the start of summer, when Rossy said the weather was “terrible.”

“The weather got slightly better towards the end of the summer and our sales certainly increased, but not enough to make up for the season’s horrible start,” he said.

Sales totalled $1.56 billion for the quarter, up from $1.46 billion in the same quarter last year.

Comparable store sales, a key metric for retailers, increased 4.7 per cent, while the average transaction was down2.2 per cent and traffic was up seven per cent, RBC analyst Irene Nattel pointed out.

She told investors in a note that the numbers reflect “solid demand as cautious consumers focus on core consumables and everyday essentials.”

Analysts have attributed such behaviour to interest rates that have been slow to drop and high prices of key consumer goods, which are weighing on household budgets.

To cope, many Canadians have spent more time seeking deals, trading down to more affordable brands and forgoing small luxuries they would treat themselves to in better economic times.

“When people feel squeezed, they tend to shy away from discretionary, focus on the basics,” Rossy said. “When people are feeling good about their wallet, they tend to be more lax about the basics and more willing to spend on discretionary.”

The current economic situation has drawn in not just the average Canadian looking to save a buck or two, but also wealthier consumers.

“When the entire economy is feeling slightly squeezed, we get more consumers who might not have to or want to shop at a Dollarama generally or who enjoy shopping at a Dollarama but have the luxury of not having to worry about the price in some other store that they happen to be standing in that has those goods,” Rossy said.

“Well, when times are tougher, they’ll consider the extra five minutes to go to the store next door.”

This report by The Canadian Press was first published Sept. 11, 2024.

Companies in this story: (TSX:DOL)

Source link

Continue Reading

Business

U.S. regulator fines TD Bank US$28M for faulty consumer reports

Published

 on

 

TORONTO – The U.S. Consumer Financial Protection Bureau has ordered TD Bank Group to pay US$28 million for repeatedly sharing inaccurate, negative information about its customers to consumer reporting companies.

The agency says TD has to pay US$7.76 million in total to tens of thousands of victims of its illegal actions, along with a US$20 million civil penalty.

It says TD shared information that contained systemic errors about credit card and bank deposit accounts to consumer reporting companies, which can include credit reports as well as screening reports for tenants and employees and other background checks.

CFPB director Rohit Chopra says in a statement that TD threatened the consumer reports of customers with fraudulent information then “barely lifted a finger to fix it,” and that regulators will need to “focus major attention” on TD Bank to change its course.

TD says in a statement it self-identified these issues and proactively worked to improve its practices, and that it is committed to delivering on its responsibilities to its customers.

The bank also faces scrutiny in the U.S. over its anti-money laundering program where it expects to pay more than US$3 billion in monetary penalties to resolve.

This report by The Canadian Press was first published Sept. 11, 2024.

Companies in this story: (TSX:TD)

The Canadian Press. All rights reserved.

Source link

Continue Reading

Business

Amazon rejects plea to stop selling taxi roof signs as cab scam spreads across Canada

Published

 on

After a long day at a work event in July, Kathryn Kozody was relieved when she spotted a car with a lit-up taxi sign.

She thought it was odd when the driver told her she’d have to pay her fare with a debit card. Still, a tired Kozody hopped in the car.

“I was like, ‘Fine, it’s kind of weird, but let’s go home,'” said Kozody, who lives in Calgary.

Nothing else seemed off — until the next day when she discovered that almost $2,000 was missing from her bank account. On top of that, her debit card had someone else’s name on it.

Kozody concluded that the taxi driver was a fraudster who, during the debit card transaction, recorded her PIN, stole her card and handed her back a fake.

“I started freaking out,” she said. “It’s terrifying when they have your debit card.”

It took Kozody about two weeks to get her money back from her bank, and she’s still rattled by the experience.

 Kathryn Kozody standing on the street
The day after taking what she thought was a ride in a taxi, Kathryn Kozody of Calgary found out someone had withdrawn almost $2,000 from her bank account. (James Young/CBC News)

“It really felt like an invasion of privacy and a violation to be a victim of this scam,” she said. “I really don’t want it to happen to anybody else.”

The taxi scam isn’t new; Toronto and Montreal have been seeing it for years. But the crime is becoming more widespread.

This summer, police in Calgary, Edmonton and at least five cities in southern Ontario, including Kingston and Ottawa, posted warnings online that they had received multiple reports of the scam.

Police and the Canadian Taxi Association say the fraudsters have a helping hand: with the click of a button, they can purchase a generic — but official looking — taxi roof sign on e-commerce sites like Amazon.

A Facebook post by the Edmonton Police.
Edmonton Police posted this alert on Facebook in July, warning people about an ongoing taxi scam. The city’s police department says that it received about 10 reports of the scam that month. (Edmonton Police/Facebook )

The taxi association has asked Amazon, by far Canada’s most popular online shopping site, to stop making the roof signs so easily available.

“They do have a moral responsibility to at least sell the signs to individuals that are properly licensed,” said association president Marc André Way.

However, the U.S.-based company continues to sell the product to all customers.

“These lights are legal to sell in Canada,” Amazon told CBC News in an email.

‘Eye-popping’ numbers

The taxi scam has several variations but typically ends the same way: the victim pays with a debit card, then the scammer secretly steals it and hands the victim a similar but fake card. Shortly thereafter, money disappears from the victim’s account.

Ron Hansen, deputy chief of police in Sarnia, Ont., said his department received 12 reports of the scam in July, with one victim losing $9,900.

Toronto police report that since June 2023 the department has received 919 reports of the taxi scam, totalling $1.7 million in losses.

Jessica Chin King standing on the street.
Jessica Chin King of Toronto said after a recent cab ride, she got a suspicious activity alert from her bank. She learned $600 had been withdrawn from her account. (Craig Chivers/CBC)

The numbers are “eye-popping,” said Toronto police detective David Coffey.

“When they do get a victim, they are quick to go right into the bank accounts. They’re quick to empty them out.”

Jessica Chin King of Toronto said just 15 minutes after a recent cab ride, she got a suspicious activity alert from her bank. Turns out, $600 had been withdrawn from her account.

“I was like, ‘Wow, I can’t believe that just happened.’ I was in shock,” said Chin King, whose bank later reimbursed the cash.

She said she too was fooled by the taxi sign atop the car.

“I was in the car with somebody who wasn’t a taxi driver. Anything could have happened,” she said. “I was thankful that it was only my bank [account] that was compromised.”

Taxi light for $35 on Amazon

CBC News bought a taxi sign from Amazon for $35. It has a magnetic strip on the bottom, so it easily sticks to the top of a car.

To power the light, an attached wire can be run through the driver’s window and plugged into the car’s auxiliary power outlet, also known as the cigarette lighter outlet.

The taxi association says licensed taxi drivers typically get their roof signs from speciality suppliers, and they are hardwired to the car — not powered via the cigarette lighter.

“When you see that … it’s obvious that it’s not a legitimate taxi,” said Way, the association president.

Last month, Way sent Amazon a letter on behalf of the Canadian Taxi Association, asking it to stop selling the product.

“This is not a safe, practical way to distribute the trusted ‘Taxi’ signs,” he wrote.

A yellow taxi sign with an attached wire.
CBC News ordered this $35 taxi sign on Amazon. The attached wire can be run through the driver’s window and plugged into the car’s auxiliary power outlet, while the lights for licensed drivers are hardwired into the vehicle. (Sophia Harris/CBC News)

But Amazon told Way — and CBC News — the signs will remain on its site, because the company isn’t breaking any rules.

“It’s going to be quite difficult, I think, for anyone to stop Amazon from selling a product that is perfectly legal to sell,” said Toronto criminal lawyer, Daniel Goldbloom. “It’s true that these taxi signs can be used to commit scams, but kitchen knives can be used to commit murder — and we don’t stop retailers from selling those.”

But Way isn’t giving up hope.

He says the taxi association also plans to ask other online retailers, such as Temu and eBay, to stop selling the taxi signs and will lobby provincial governments for legislation that regulates the sale of the product.

However, Coffey said he believes the best way to fight the taxi scam is to educate people about it.

“Never, never give another person control of your debit card,” the detective said.

Victims Chin King and Kozody also want to spread the word.

“The more people know, the less likely it is to happen again to somebody else,” Kozody said.

728x90x4

Source link

Continue Reading

Trending